These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23544327)

  • 21. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
    Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
    Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
    Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense.
    Trapnell BC; Whitsett JA
    Annu Rev Physiol; 2002; 64():775-802. PubMed ID: 11826288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates.
    Rose RM; Kobzik L; Dushay K; Wolfthal S; Hondalus M; Metzger M; Stoudemire J; Brain JD; Garnick M; O'Donnell C
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1279-86. PubMed ID: 1443885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies.
    Khan A; Agarwal R; Aggarwal AN
    Chest; 2012 May; 141(5):1273-1283. PubMed ID: 22016491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF Biology.
    Hamilton JA; Anderson GP
    Growth Factors; 2004 Dec; 22(4):225-31. PubMed ID: 15621725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Jones TC
    Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
    Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
    J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary alveolar proteinosis--is host defense awry?
    Doerschuk CM
    N Engl J Med; 2007 Feb; 356(6):547-9. PubMed ID: 17287475
    [No Abstract]   [Full Text] [Related]  

  • 36. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies.
    Dranoff G; Mulligan RC
    Stem Cells; 1994; 12 Suppl 1():173-82; discussion 182-4. PubMed ID: 7696961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The granulocyte/macrophage-colony stimulating factor (GM-CSF): basic science and clinical application.
    Burdach S
    Klin Padiatr; 1991; 203(4):302-10. PubMed ID: 1942937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.